DEEPA JOSEPH: Open Payments
NPI 1932899788 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 32 payments from 13 companies in 2025. Trend: 2023 $324 · 2024 $1,154 · 2025 $1,131
Food & beverage: $919Education: $212
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $371 |
| Syndax Pharmaceuticals, Inc. | 6 | $195 |
| AstraZeneca Pharmaceuticals LP | 3 | $101 |
| Incyte Corporation | 3 | $87 |
| SOBI, INC | 2 | $67 |
| Merck Sharp & Dohme LLC | 2 | $62 |
| Lilly USA, LLC | 2 | $62 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
| Celgene Corporation | 1 | $34 |
| ABBVIE INC. | 1 | $33 |
Products named: CALQUENCE, Cresemba, JAKAFI, Vonjo, Xospata, REBLOZYL, JAYPIRCA, INQOVI.
Industry payments across TX — which companies pay providers there.
